Arch Dermatol Res
Archives of Dermatological Research
0340-3696
1432-069X
Springer-Verlag
Berlin/Heidelberg


1839867
17277959
734
10.1007/s00403-007-0734-0
Review Article


The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases

Sitaru
Cassian

+49-451-5002530
+49-451-5002981
csitaru@fastmail.fm



Mihai
Sidonia



Zillikens
Detlef



Department of Dermatology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany 

3
2
2007

4
2007

299
1
1
8
13
11
2006

20
12
2006

8
1
2007


© Springer-Verlag 2007

Autoimmune bullous skin diseases are characterized by autoantibodies and T cells specific to structural proteins maintaining cell–cell and cell–matrix adhesion in the skin. Existing clinical and experimental evidence generally supports a pathogenic role of autoantibodies for blister formation. These autoantibodies belong to several IgG subclasses, which associate with different functional properties and may thus determine the pathogenic potential of IgG antibodies. In pemphigus diseases, binding of IgG to keratinocytes is sufficient to cause intraepidermal blisters without engaging innate immune effectors and IgG4 autoantibodies seem to mainly mediate acantholysis. In contrast, in most subepidermal autoimmune blistering diseases, complement activation and recruitment and activation of leukocytes by autoantibodies are required for blister induction. In these conditions, tissue damage is thought to be mainly mediated by IgG1, but not IgG4 autoantibodies. This review summarizes the current knowledge on the pathogenic relevance of the IgG subclass of autoantibodies for blister formation. Characterization of the pathogenically relevant subclass(es) of autoantibodies not only provides mechanistic insights, but should greatly facilitate the development of improved therapeutic modalities of autoimmune blistering diseases.

Keywords
Autoimmune bullous diseases
IgG subclasses
Complement

issue-copyright-statement
© Springer-Verlag 2007




Introduction
62
66
39
71
62
85
62
].
62
].
20
27
77
35
56
59
76
80
82
35
56
80
82
].
The pathogenic potential unfolded by autoantibodies is determined not only by their specificity and affinity, but also by their isotype. Autoantibodies against cutaneous proteins in autoimmune blistering diseases belong to different IgG subclasses. This paper summarizes the current knowledge on the relevance of IgG subclasses for tissue injury in autoimmune bullous diseases.

Pemphigus diseases
39
54
71
62
4
21
45
55
].
2
5
8
9
16
18
23
28
36
38
40
49
61
79
1
5
17
23
40
52
78
9
42
86
57
29
24
Fig. 1
a
d
b
c
 IgG3 autoantibodies was evidenced




3
50
]. These results demonstrate that non-complement-fixing autoantibodies can induce acantholysis and suggest a similar mechanism in patients, but they do not exclude a pathogenic potential of patients’ IgG1 autoantibodies in pemphigus.
In conclusion, in pemphigus diseases the autoantibodies mainly belong to the IgG4 and IgG1 subclasses. Extensive experimental evidence demonstrates the blister-inducing potential of IgG4 autoantibodies. The pathogenic activity of autoantibodies of other subclasses seems likely, but needs further investigation.

Subepidermal autoimmune blistering diseases
Bullous pemphigoid and pemphigoid gestationis
87
62
66
48
65
88
].
44
84
31
64
].
1
10
12
22
61
83
10
11
61
83
2
6
19
32
41
69
Fig. 2
lane 1
lane 4
lane 2
lane 3
) autoantibodies




14
37
53
], a pattern similar to the one found in bullous pemphigoid. Further studies should solve this contradiction.
43
32
3
46
72
4
46
33
70
46
Fig. 3
a
b
c
 In contrast, incubation of cryosections with IgG4 specific for the dermal–epidermal junction does not result in C3 deposition (all magnifications, ×200)



Fig. 4
a 
b
c
 IgG antibodies from a healthy control (NHS) do not induce subepidermal splits (all magnifications, ×200)




58
73
75
58
2+
73
75
73
2+
74
].

Mucous membrane pemphigoid
62
66
7
34
34
34
60
34
60
].

Diseases associated with autoimmunity against type VII collagen
60
63
67
81
68
].
7
15
26
47
68
68
].
13
25
30
51
30
51
51
30
]. This findings suggest that the presence of complement-fixing autoantibodies is not a strict requirement for blistering in patients.


Conclusion and perspectives
The polyclonal antibody response against structural skin proteins in autoimmune bullous diseases is heterogeneous, but shows a skewing in subclass distribution of autoantibodies. The strong bias toward production of IgG4 autoantibodies in these organ-specific autoimmune diseases suggests chronic antigenic stimulation. In pemphigus, IgG4 autoantibodies that dominate the autoimmune response are clearly pathogenic. However, IgG1 autoantibodies also likely possess blister-inducing potential that requires further investigation. In subepidermal autoimmune blistering diseases, the effector functions of autoantibodies are important for blistering. Thus, in bullous pemphigoid and epidermolysis bullosa acquisita, complement-fixing IgG1 autoantibodies may show a significantly higher pathogenic potential when compared with IgG4 autoantibodies. Characterization of the blister-inducing capacity of different subclasses of autoantibodies in autoimmune bullous diseases will not only provide relevant mechanistic insights, but should also greatly facilitate the development of improved therapeutic modalities of autoimmune blistering diseases. Detailed knowledge on the pathogenic IgG isotype(s) will serve as a basis for the development of IgG subclass-specific immunoapheresis, skewing autoantibody production toward non-pathogenic subclasses by immunotherapy or blocking of complement or leukocytes activation by targeting specific IgG subclasses. A promising approach is represented by interventions aimed at inhibiting the production of autoantibodies in general or skewing the production of autoantibodies toward non-pathogenic subclasses. The molecular targets of these approaches may include different cytokines (e.g., IL-12 and IL-17) and their activity could be modulated using inhibitory antibodies, small peptide inhibitors or peptidomimetics as well as immunization with the autoantigen together with adjuvants known to induce a Th2 immune response.


This work was supported by grants from the Deutsche Forschungsgemeinschaft (Zi 439/6-2 and SI 1281/1-1) and Else-Kröner-Fresenius-Stiftung (P30-06//A24/06).

References
1.
Al-Karawi
KS


Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies
Saudi Med J
2002
23
1492
1495

12518199


2.
Allen
EM

Giudice
GJ

Diaz
LA


Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein
J Invest Dermatol
1993
100
685
691
10.1111/1523-1747.ep12472348

8491991


3.
Amagai
M

Tsunoda
K

Suzuki
H

Nishifuji
K

Koyasu
S

Nishikawa
T


Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus
J Clin Invest
2000
105
625
631

10712434


4.
Anhalt
GJ

Till
GO

Diaz
LA

Labib
RS

Patel
HP

Eaglstein
NF


Defining the role of complement in experimental pemphigus vulgaris in mice
J Immunol
1986
137
2835
2840

3760574


5.
Ayatollahi
M

Joubeh
S

Mortazavi
H

Jefferis
R

Ghaderi
A


IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris
J Eur Acad Dermatol Venereol
2004
18
241
242
10.1111/j.1468-3083.2004.00708.x

15009326


6.
Bernard
P

Aucouturier
P

Denis
F

Bonnetblanc
JM


Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid
Clin Immunol Immunopathol
1990
54
484
494
10.1016/0090-1229(90)90060-4

1689231


7.
Bernard
P

Prost
C

Aucouturier
P

Durepaire
N

Denis
F

Bonnetblanc
JM


The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita
J Invest Dermatol
1991
97
259
263
10.1111/1523-1747.ep12480369

2071938


8.
Bhol
K

Mohimen
A

Ahmed
AR


Correlation of subclasses of IgG with disease activity in pemphigus vulgaris
Dermatology
1994
189
85
89

8049571


9.
Bhol
K

Natarajan
K

Nagarwalla
N

Mohimen
A

Aoki
V

Ahmed
AR


Correlation of peptide specificity and IgG subclass with pathogenic and non-pathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity
Proc Natl Acad Sci USA
1995
92
5239
5243
10.1073/pnas.92.11.5239

7761479


10.
Bird
P

Friedmann
PS

Ling
N

Bird
AG

Thompson
RA


Subclass distribution of IgG autoantibodies in bullous pemphigoid
J Invest Dermatol
1986
86
21
25
10.1111/1523-1747.ep12283737

3528304


11.
Brooks
WS

Lee
YY

Abell
E

Deng
JS


Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus
J Clin Lab Anal
1989
3
307
311
10.1002/jcla.1860030509

2681622


12.
Buschman
KE

Seraly
M

Thong
HY

Deng
JS

Draviam
RP

Abernethy
JL


A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid
J Cutan Pathol
2002
29
282
286
10.1034/j.1600-0560.2002.290504.x

12100628


13.
Chen
M

O’Toole
EA

Sanghavi
J

Mahmud
N

Kelleher
D

Weir
D

Fairley
JA

Woodley
DT


The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn’s disease have autoantibodies to type VII collagen
J Invest Dermatol
2002
118
1059
1064
10.1046/j.1523-1747.2002.01772.x

12060403


14.
Chimanovitch
I

Schmidt
E

Messer
G

Dopp
R

Partscht
K

Bröcker
EB

Giudice
GJ

Zillikens
D


IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis
J Invest Dermatol
1999
113
140
142
10.1046/j.1523-1747.1999.00622.x

10417635


15.
Cho
HJ

Lee
IJ

Kim
SC


Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita
Yonsei Med J
1998
39
339
344

9752800


16.
David
M

Katzenelson
V

Hazaz
B

Ben-Chetrit
A

Sandbank
M


Determination of IgG subclasses in patients with pemphigus with active disease and in remission
Arch Dermatol
1989
125
787
790
10.1001/archderm.125.6.787

2658844


17.
David
M

Katzenelson
V

Mimouni
D

Milner
Y


The distribution of pemphigus vulgaris-IgG subclasses in patients with active disease
J Eur Acad Dermatol Venereol
2006
20
232
10.1111/j.1468-3083.2006.01393.x

16441649


18.
Dmochowski
M

Hashimoto
T

Nishikawa
T


The analysis of IgG subclasses of anti-intercellular antibodies in pemphigus by an immunoblot technique
Arch Dermatol Res
1992
284
309
311
10.1007/BF00372587

1444582


19.
Döpp
R

Schmidt
E

Chimanovitch
I

Leverkus
M

Bröcker
EB

Zillikens
D


IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity
J Am Acad Dermatol
2000
42
577
583
10.1016/S0190-9622(00)90168-3

10727301


20.
Dray
S


Three gamma-globulins in normal human serum revealed by monkey precipitins
Science
1960
132
1313
1314
10.1126/science.132.3436.1313

13724290


21.
Espana
A

Diaz
LA

Mascaro
JM

Giudice
GJ

Fairley
JA

Till
GO

Liu
Z


Mechanisms of acantholysis in pemphigus foliaceus
Clin Immunol Immunopathol
1997
85
83
89
10.1006/clin.1997.4407

9325073


22.
Flotte
TJ

Baird
LG


Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis
J Immunol
1986
136
491
496

3079787


23.
Futei
Y

Amagai
M

Ishii
K

Kuroda-Kinoshita
K

Ohya
K

Nishikawa
T


Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus
J Dermatol Sci
2001
26
55
61
10.1016/S0923-1811(00)00158-4

11323221


24.
Futei
Y

Amagai
M

Hashimoto
T

Nishikawa
T


Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus
J Am Acad Dermatol
2003
49
1023
1028
10.1016/S0190-9622(03)02160-1

14639380


25.
Gammon
WR

Briggaman
RA


Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen
Dermatol Clin
1993
11
535
547
10.1016/0738-081X(93)90162-6

8365038


26.
Gandhi
K

Chen
M

Aasi
S

Lapiere
J-C

Woodley
D

Chan
LC


Autoantibodies to type VII collagen have heterogenous subclass and light chain compositions and their complement-activating capacitities do not correlate with the inflammatory clinical phenotype
J Clin Immunol
2000
20
416
423
10.1023/A:1026451530967

11202231


27.
Grey
HM

Kunkel
HG


H-chain subgroups of myeloma proteins and normal 7s-gammaglobulins
J Exp Med
1964
120
253
266
10.1084/jem.120.2.253

14206440


28.
Hacker
MK

Janson
M

Fairley
JA

Lin
MS


Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies
Clin Immunol
2002
105
64
74
10.1006/clim.2002.5259

12483995


29.
Hacker-Foegen
MK

Janson
M

Amagai
M

Fairley
JA

Lin
MS


Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies
J Invest Dermatol
2003
121
1373
1378
10.1111/j.1523-1747.2003.12608.x

14675185


30.
Herrero-Gonzalez
JE

Mascaro
JM

Herrero
C

Dilling
A

Zillikens
D

Sitaru
C


Autoantibodies from bullous systemic lupus erythematosus patients induce recruitment of leukocytes to the dermal–epidermal junction and subepidermal splits in cryosections of human skin
Arch Dermatol
2006a
142
1
3
10.1001/archderm.142.11.1513

Herrero-Gonzalez JE, Mascaro JM, Herrero C, Dilling A, Zillikens D, Sitaru C (2006a) Autoantibodies from bullous systemic lupus erythematosus patients induce recruitment of leukocytes to the dermal–epidermal junction and subepidermal splits in cryosections of human skin. Arch Dermatol 142:1–3 

31.
Herrero-Gonzalez
JE

Brauns
O

Egner
R

Ronspeck
W

Mascaro
JM

Jonkman
MF

Zillikens
D

Sitaru
C


Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal–epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients
Eur J Immunol
2006b
36
1039
1048
10.1002/eji.200535349

16552711


32.
Hofmann
S

Thoma-Uszynski
S

Hunziker
T

Bernard
P

Koebnick
C

Stauber
A

Schuler
G

Borradori
L

Hertl
M


2
- and COOH-terminal regions of the BP180 ectodomain
J Invest Dermatol
2002
119
1065
1073
10.1046/j.1523-1747.2002.19529.x

12445194


33.
Holland
M

Hewins
P

Goodall
M

Adu
D

Jefferis
R

Savage
CO


Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass
Clin Exp Immunol
2004
138
183
192
10.1111/j.1365-2249.2004.02566.x

15373923


34.
Hsu
R

Lazarova
Z

Yee
C

Yancey
KB


Non-complement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid
J Invest Dermatol
1997
109
557
561
10.1111/1523-1747.ep12337073

9326390


35.
Janeway
CA

Travers
P

Walport
M

Shlomchik
M


Immunobiology
2001
5th edn
New York
Garland
360
361

Janeway CA, Travers P, Walport M, Shlomchik M (2001) Immunobiology, 5th edn. Garland, New York, pp 360–361 

36.
Jones
CC

Hamilton
RG

Jordon
RE


Subclass distribution of human IgG autoantibodies in pemphigus
J Clin Immunol
1988
8
43
49
10.1007/BF00915155

3284896


37.
Kelly
SE

Cerio
R

Bhogal
BS

Black
MM


The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody
J Invest Dermatol
1989
92
695
698
10.1111/1523-1747.ep12696884

2654296


38.
Kim
YH

Geoghegan
WD

Jordon
RE


Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes
J Lab Clin Med
1990
115
324
331

2179435


39.
Kottke
MD

Delva
E

Kowalczyk
AP


The desmosome: cell science lessons from human diseases
J Cell Sci
2006
119
797
806
10.1242/jcs.02888

16495480


40.
Kricheli
D

David
M

Frusic-Zlotkin
M

Goldsmith
D

Rabinov
M

Sulkes
J

Milner
Y


The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives (see comments)
Br J Dermatol
2000
143
337
342
10.1046/j.1365-2133.2000.03659.x

10951142


41.
Laffitte
E

Skaria
M

Jaunin
F

Tamm
K

Saurat
JH

Favre
B

Borradori
L


Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses
Br J Dermatol
2001
144
760
768
10.1046/j.1365-2133.2001.04130.x

11298534


42.
Li
N

Aoki
V

Hans-Filho
G

Rivitti
EA

Diaz
LA


The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)
J Exp Med
2003
197
1501
1510
10.1084/jem.20022031

12771179


43.
Liu
Z


Are anti-BP180 IgG1 or IgG4 autoantibodies pathogenic?
J Invest Dermatol
2002
119
989
990
10.1046/j.1523-1747.2002.19534.x

12445182


44.
Liu
Z

Diaz
LA

Troy
JL

Taylor
AF

Emery
DJ

Fairley
JA

Giudice
GJ


A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180
J Clin Invest
1993
92
2480
2488

7693763


45.
Mascaro
JM

Espana
A

Liu
Z

Ding
X

Swartz
SJ

Fairley
JA

Diaz
LA


Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence
Clin Immunol Immunopathol
1997
85
90
96
10.1006/clin.1997.4408

9325074


46.
Mihai S, Chiriac MT, Herrero-Gonzales JE, Godall M, Jefferies AR, Savage CO, Zillikens D, Sitaru C (2007) Non-complement fixing IgG4 autoantibodies from patients with bullous pemphigoid activate leukocytes and induce dermal–epidermal separation. (submitted)

47.
Mooney
E

Gammon
WR


Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita
J Invest Dermatol
1990
95
317
319
10.1111/1523-1747.ep12485033

2117036


48.
Morrison
LH

Labib
RS

Zone
JJ

Diaz
LA

Anhalt
GJ


Herpes gestationis autoantibodies recognize a 180-kDa human epidermal antigen
J Clin Invest
1988
81
2023
2026

3290259


49.
Ogawa
MM

Hashimoto
T

Nishikawa
T

Castro
RM


IgG subclasses of intercellular antibodies in Brazilian pemphigus foliaceus—the relationship to complement fixing capability
Clin Exp Dermatol
1989
14
29
31
10.1111/j.1365-2230.1989.tb00878.x

2680177


50.
Ohyama
M

Amagai
M

Tsunoda
K

Ota
T

Koyasu
S

Hata
J

Umezawa
A

Nishikawa
T


Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris
J Invest Dermatol
2002
118
199
204
10.1046/j.0022-202x.2001.01643.x

11851895


51.
Oostingh
GJ

Sitaru
C

Kromminga
A

Lührs
H

Zillikens
D


Subclass distribution of collagen type VII specific autoantibodies in patients with inflammatory bowel diseases
J Dermatol Sci
2005
37
182
184
10.1016/j.jdermsci.2004.11.010

15734289


52.
Parlowsky
T

Welzel
J

Amagai
M

Zillikens
D

Wygold
T


Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns
J Am Acad Dermatol
2003
48
623
625
10.1067/mjd.2003.170

12664033


53.
Patton
T

Plunkett
RW

Beutner
EH

Deng
JS

Jukic
DM


IgG4 as the predominant IgG subclass in pemphigoides gestationis
J Cutan Pathol
2006
33
299
302
10.1111/j.0303-6987.2006.00458.x

16630180


54.
Payne
AS

Hanakawa
Y

Amagai
M

Stanley
JR


Desmosomes and disease: pemphigus and bullous impetigo
Curr Opin Cell Biol
2004
16
536
543
10.1016/j.ceb.2004.07.006

15363804


55.
Payne
AS

Ishii
K

Kacir
S

Lin
C

Li
H

Hanakawa
Y

Tsunoda
K

Amagai
M

Stanley
JR

Siegel
DL


Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display
J Clin Invest
2005
115
888
899
10.1172/JCI200524185

15841178


56.
Ravetch
JV

Bolland
S


IgG Fc receptors
Annu Rev Immunol
2001
19
275
290
10.1146/annurev.immunol.19.1.275

11244038


57.
Rock
B

Martins
CR

Theofilopoulos
AN

Balderas
RS

Anhalt
GJ

Labib
RS

Futamura
S

Rivitti
EA

Diaz
LA


The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)
N Engl J Med
1989
320
1463
1469

2654636


58.
Schmidt
E

Reimer
S

Kruse
N

Jainta
S

Bröcker
EB

Marinkovich
MP

Giudice
GJ

Zillikens
D


Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes
J Invest Dermatol
2000
115
842
848
10.1046/j.1523-1747.2000.00141.x

11069622


59.
Schur PH (1987) IgG subclasses—a review. Ann Allergy 58:89–96, 99

60.
Shimanovich
I

Mihai
S

Oostingh
GJ

Ilenchuk
TT

Brocker
EB

Opdenakker
G

Zillikens
D

Sitaru
C


Granulocyte-derived elastase and gelatinase B are required for dermal–epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid
J Pathol
2004
204
519
527
10.1002/path.1674

15538734


61.
Shirakata
Y

Shiraishi
S

Sayama
K

Miki
Y


Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus
J Dermatol
1990
17
661
666

2094743


62.
Sitaru
C

Zillikens
D


Mechanisms of blister induction by autoantibodies
Exp Dermatol
2005
14
861
875
10.1111/j.1600-0625.2005.00367.x

16274453


63.
Sitaru
C

Kromminga
A

Hashimoto
T

Bröcker
EB

Zillikens
D


Autoantibodies to type VII collagen mediate Fcgamma-dependent granulocyte activation and induce dermal–epidermal separation in cryosections of human skin
Am J Pathol
2002a
161
301
311

12107115


64.
Sitaru
C

Schmidt
E

Petermann
S

Munteanu
SL

Bröcker
EB

Zillikens
D


Autoantibodies to bullous pemphigoid antigen 180 induce dermal–epidermal separation in cryosections of human skin
J Invest Dermatol
2002b
118
664
671
10.1046/j.1523-1747.2002.01720.x

11918714


65.
Sitaru
C

Powell
J

Shimanovich
I

Jainta
S

Kirtschig
G

Wojnarowska
F

Zillikens
D


Pemphigoid gestationis: maternal sera recognise epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain
Br J Dermatol
2003
149
420
422
10.1046/j.1365-2133.2003.05427.x

12932258


66.
Sitaru
C

Goebeler
M

Zillikens
D


Bullöse Autoimmundermatosen (I): Pathogenese und Diagnostik
JDDG
2004
2
123
139
10.1046/j.1439-0353.2004.03642.x

16279248


67.
Sitaru
C

Mihai
S

Otto
C

Chiriac
MT

Haußer
I

Dotterweich
B

Saito
H

Rose
C

Ishiko
A

Zillikens
D


Induction of dermal–epidermal separation in mice by passive transfer of antibodies to type VII collagen
J Clin Invest
2005
115
870
878
10.1172/JCI200521386

15841176


68.
Sitaru
C

Chiriac
MT

Mihai
S

Büning
J

Gebert
A

Ishiko
A

Zillikens
D


Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice
J Immunol
2006
177
3461
3468

16920988


69.
Skaria
M

Jaunin
F

Hunziker
T

Riou
S

Schumann
H

Bruckner-Tuderman
L

Hertl
M

Bernard
P

Saurat
JH

Favre
B

Borradori
L


IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230
J Invest Dermatol
2000
114
998
1004
10.1046/j.1523-1747.2000.00893.x

10771483


70.
Soundararajan
S

Kikuchi
Y

Joseph
K

Kaplan
AP


Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria
J Allergy Clin Immunol
2005
115
815
821
10.1016/j.jaci.2004.12.1120

15806004


71.
Stanley
JR

Amagai
M


Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome
N Engl J Med
2006
355
1800
1810
10.1056/NEJMra061111

17065642


72.
Suzuki
M

Harada
S

Yaoita
H


Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation
Acta Derm Venereol
1992
72
245
249

1357875


73.
Suzuki
M

Harada
S

Owaribe
K

Yaoita
H


Intracellular ionic changes induced by bullous pemphigoid IgG subclasses
Autoimmunity
1996
23
181
197

8879454


74.
Suzuki
M

Harada
S

Yaoita
H

Nakagawa
H


2+
 induced by bullous pemphigoid IgG1 antibody
Autoimmunity
1999
30
85
91

10435721


75.
Suzuki
M

Murata
S

Yaoita
H

Nakagawa
H


2+
 concentration in DJM-1 (human squamous cell carcinoma) cells
Autoimmunity
2002
35
271
276
10.1080/0891693021000010721

12482196


76.
Tao
MH

Smith
RI

Morrison
SL


Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation
J Exp Med
1993
178
661
667
10.1084/jem.178.2.661

8340761


77.
Terry
WD

Fahey
JL


Subclasses of human gamma-2-globulin based on differences in the heavy polypeptide chains
Science
1964
146
400
401
10.1126/science.146.3642.400

14186462


78.
Warren
SJ

Arteaga
LA

Rivitti
EA

Aoki
V

Hans-Filho
G

Qaqish
BF

Lin
MS

Giudice
GJ

Diaz
LA


The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus
J Invest Dermatol
2003
120
104
108
10.1046/j.1523-1747.2003.12017.x

12535205


79.
Wilson
CL

Wojnarowska
F

Dean
D

Pasricha
JS


IgG subclasses in pemphigus in Indian and UK populations
Clin Exp Dermatol
1993
18
226
230
10.1111/j.1365-2230.1993.tb02175.x

8348715


80.
Winkel
JG

Capel
PJ


Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications
Immunol Today
1993
14
215
221
10.1016/0167-5699(93)90166-I

8517920


81.
Woodley
DT

Ram
R

Doostan
A

Bandyopadhyay
P

Huang
Y

Remington
J

Hou
Y

Keene
DR

Liu
Z

Chen
M


Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients
J Invest Dermatol
2006
126
1323
1330
10.1038/sj.jid.5700254

16543893


82.
Woof
JM

Burton
DR


Human antibody–Fc receptor interactions illuminated by crystal structures
Nat Rev Immunol
2004
4
89
99
10.1038/nri1266

15040582


83.
Yamada
H

Hashimoto
T

Nishikawa
T


IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation
J Invest Dermatol
1989
92
585
587
10.1111/1523-1747.ep12709613

2649595


84.
Yamamoto
K

Inoue
N

Masuda
R

Fujimori
A

Saito
T

Imajoh-Ohmi
S

Shinkai
H

Sakiyama
H


Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid
J Invest Dermatol
2002
118
485
492
10.1046/j.0022-202x.2001.01683.x

11874488


85.
Yancey
KB


The pathophysiology of autoimmune blistering diseases
J Clin Invest
2005
115
825
828
10.1172/JCI200524855

15841169


86.
Yeh
SW

Cavacini
LA

Bhol
KC

Lin
MS

Kumar
M

Duval
M

Posner
MR

Ahmed
AR


Pathogenic human monoclonal antibody against desmoglein 3
Clin Immunol
2006
120
68
75
10.1016/j.clim.2006.03.006

16635589


87.
Zillikens
D


Acquired skin disease of hemidesmosomes
J Dermatol Sci
1999
20
134
154
10.1016/S0923-1811(99)00019-5

10379705


88.
Zillikens
D

Rose
PA

Balding
SD

Liu
Z

Olague-Marchan
M

Diaz
LA

Giudice
GJ


Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies
J Invest Dermatol
1997
109
573
579
10.1111/1523-1747.ep12337492

9326393





